Aldeyra Therapeutics (ALDX) Falls Below $5.40 as FDA Decision Looms
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) is a Massachusetts-based clinical-stage biotechnology company focused on discovering and developing novel therapies designed…
Browsing Tag